Hypotensive lipid (prostaglandin derivatives) and timolol compositions and methods of using same

Details for Australian Patent Application No. 2002312221 (hide)

International Classifications

Event Publications

2 January 2003 Complete Application Filed

Priority application(s): 60/294,845 31.05.01 US

8 May 2003 Application Open to Public Inspection

Published as AU-B-2002312221

15 February 2007 Application Accepted

Published as AU-B-2002312221

14 June 2007 Standard Patent Sealed

3 December 2009 Extension of Term of Standard Patents

Allergan, Inc. The earliest first regulatory approval date provided by the patentee 15 May 2009 For the goods GANFORT bimatoprost

21 January 2010 Extension of Term of Standard Patents

Allergan, Inc. The earliest first regulatory approval date provided by the patentee 15 May 2009 For the goods GANFORT bimatoprost Address for service in Australia: Davies Collison Cave 255 Elizabeth Street Sydney NSW 2000

3 June 2010 Extension granted

Allergan, Inc. The earliest first regulatory approval date provided by the patentee 15 May 2009 For the goods GANFORT bimatoprost Extension of Term of patent pursuant to Section 77 expires on 15 May 2024

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.